Mameli et al., 2012 - Google Patents
Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosisMameli et al., 2012
View HTML- Document ID
- 8554399959174014586
- Author
- Mameli G
- Poddighe L
- Mei A
- Uleri E
- Sotgiu S
- Serra C
- Manetti R
- Dolei A
- Publication year
External Links
Snippet
Background Proposed co-factors triggering the pathogenesis of multiple sclerosis (MS) are the Epstein Barr virus (EBV), and the potentially neuropathogenic MSRV (MS-associated retrovirus) and syncytin-1, of the W family of human endogenous retroviruses …
- 201000006417 multiple sclerosis 0 title abstract description 102
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mameli et al. | Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis | |
| Grandi et al. | HERV envelope proteins: physiological role and pathogenic potential in cancer and autoimmunity | |
| Mameli et al. | Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? | |
| Laska et al. | Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis | |
| Mameli et al. | Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis | |
| Grandi et al. | Type W human endogenous retrovirus (HERV-W) integrations and their mobilization by L1 machinery: contribution to the human transcriptome and impact on the host physiopathology | |
| Wandinger et al. | Association between clinical disease activity and Epstein–Barr virus reactivation in MS | |
| Tran et al. | Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy | |
| Vingert et al. | HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity | |
| Morris et al. | Do human endogenous retroviruses contribute to multiple sclerosis, and if so, how? | |
| Mantri et al. | Cocaine enhances HIV-1 replication in CD4+ T cells by down-regulating MiR-125b | |
| Matsuura et al. | Neuroimmunity of HTLV-I infection | |
| Enose-Akahata et al. | Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) | |
| Pereira et al. | Simian immunodeficiency virus (SIV) infection influences the level and function of regulatory T cells in SIV-infected rhesus macaques but not SIV-infected sooty mangabeys | |
| Saito et al. | Immunopathogenesis of human T‐cell leukemia virus type‐1‐associated myelopathy/tropical spastic paraparesis: recent perspectives | |
| Pise-Masison et al. | Co-dependence of HTLV-1 p12 and p8 functions in virus persistence | |
| Slokar et al. | Human endogenous retroviruses as pathogenic factors in the development of schizophrenia | |
| Ezinne et al. | HTLV-1 specific CD8+ T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infection | |
| McHugh et al. | EBV renders B cells susceptible to HIV-1 in humanized mice | |
| Leal et al. | Expansion in CD39+ CD4+ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications | |
| Reuter et al. | Foxp3+ regulatory T cells control persistence of viral CNS infection | |
| Panikkar et al. | SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants | |
| Latifi et al. | The role of human endogenous retroviruses (HERVs) in multiple sclerosis and the plausible interplay between HERVs, Epstein–Barr virus infection, and vitamin D | |
| Kozako et al. | Programmed death-1 (PD-1)/PD-1 ligand pathway–mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders | |
| Moore et al. | Mucosal and peripheral Lin− HLA-DR+ CD11c/123− CD13+ CD14− mononuclear cells are preferentially infected during acute simian immunodeficiency virus infection |